Bristol-Myers Squibb Company (BMY)

20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Bristol Myers Squibb's Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51%

Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs.

Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An Opportunity

2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)

Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go Wrong

BMY or ARGX: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?

3 Stocks With Broker Rating Upgrades Amid Resilient Equity Markets

3 Dirt Cheap Dividend Stocks Worth Buying in October

Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?

Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale

5 High-Yield Dividends With Ex-Dates Days Away: Buy Before the Window Closes

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement